@CKD_ce Profile picture
Sep 7 48 tweets 65 min read
1) Welcome to our new #accredited #tweetorial on the Pathophysiology of #DKD in #T2D: Traditional Teaching and New Insights. Our expert author is Hans-Joachim Anders, MD, @hjanders_hans from @LMU_Uniklinikum of @LMU_Muenchen
2) This #accredited #tweetorial series on the foundations of #kidneydisease #DKD through the lens of #T2D is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance and is intended for healthcare providers.
3) This activity is accredited for #physicians #physicianassociates #nurses #NPs #pharmacists. Past programs still eligible for credit can be found at ckd-ce.com. Faculty disclosures & accreditation statement are at ckd-ce.com/disclosures/. FOLLOW US!
4a) Let’s start with a case. 53♂️ with new onset #T2D 2Y ago is referred for suspected #DKD in light of 3mos' dipstick proteinuria. Meds include metformin/sitagliptin. BP 143/85. BMI 31.
4b) Labs: Na 138, K 4.6, Creat 1.4, A1c 7.1%, no free LC, MG or autoantibodies, #UACR 690mg/g, sediment: 10 RBC/hpf.
Ultrasound imaging: both kidneys 10cm, 1 cyst 3 cm, cortex hyperechoic. Duplex: homogeneous perfusion
5) What is your diagnosis?

A. Definite #DKD because pt has #T2D + #macroproteinuria + #hypertension
B. Suspected #DKD but #kidney biopsy should rule out #GN or #FSGS
C. #CKD. Unlikely #DKD because at that age #CKD is usually multifactorial
6) Maybe we can all agree that the pt has #CKD plus #T2D.
In the past this combo was referred to as #DKD or #diabetic nephropathy/#DN but the 2020 @goKDIGO guidelines 🔓kdigo.org/wp-content/upl… avoid the use of these terms because ...
7) The global prevalences of both #CKD & #T2D are high & concomitance 🚫 necessarily imply causality when #CKD may be caused by e.g., #genetics, #ischemia, toxins, #autoimmunity or obstruction. In addition, example, obesity can be an upstream cause of both #CKD and of #T2D.
8) Naming any of these „#DKD“ would be misleading.
9) Wait: Researchers have spent billions 💲💶💴in research funds to understand #DKD, and companies spent billions 💲💶💴in private investments to develop cures for #DKD and the disease does not even exist?
No, there are still pts with #DKD, e.g.:
10) DKD
👉 longstanding #T1D w/o #insulinpump, poorly-controlled A1c w/o other RF for #CKD
👉 younger non-obese adults with a decade of #T2D and no other RF for #CKD
👉 #kidneybiopsy can rule out many DD and enforce #DKD, although many histo features are unspecific
11a) From a clinical perspective, #CKD +/- #diabetes is preferred also because no #DKD-specific cures exist. All approved drugs target either #DM, #CKD, or both:
11b)
#Antidiabetic drugs: #insulin, #biguanides, #sulfonylureas, inhibitors of -glucosidase, #DPP4, #SGLT2, #GLP-1 agonists
#CKD drugs: #ACEi, #ARBs, #SGLT2i, #MRA

nature.com/articles/s4158…
12) Now, we better understand (and overcome) the previous hurdles for progress.
Let`s have a look @ the decades of #DKD research concepts about #DKD pathophysiology from the different angles.
13) The perspective of the #clinician:
👉 focus on albuminuria as a hallmark of #DKD
👉 no appreciation of progressive #CKD in absence of #proteinuria
👉 ignoring that the concept fits almost all forms of #CKD
🔓journals.plos.org/plosgenetics/a…
14) Perspective of the #cellculture expert:
👉 #glucocentric view
👉 static models of #kidney cell stress
👉 missing #hemodynamics, #pressures, #metabolism, #shearstress, and adaptive mechanisms
pubmed.ncbi.nlm.nih.gov/23313806/
15a) Perspective of the pathologist:
#Tervaert classification (🔓jasn.asnjournals.org/content/21/4/5…):
👉Lesion pattern-based view but most lesions unspecific
👉Extent of global #glomerulosclerosis mirrors no more than clinical #CKD stage . . .
15b) ... but, an advantage of the pathologist's perspective:
👍#kidneybiopsy can identify alternative upstream causes of #CKD that may benefit from specific treatments
nature.com/articles/s4158…
16a) Perspective of #omics systems biologist (🔓jasn.asnjournals.org/content/28/4/1…):
👉Kidney transcriptomics: #inflammation & #fibrosis per #path
👉Urinary #proteomics➡️stress responses
👉Hierarchy & directional causality can't be determined
(cont)
16b) 👉Missed #RAAS #SGLT2 & #MRA as key tx targets
🔓jasn.asnjournals.org/content/28/4/1…
17a) Perspective of the #genetic expert: consider that genome-wide studies comparing #diabetes +/- #DKD or other comparisons revealed genetic #CKD RF unrelated to #diabetes, e.g.,
👉#Alport-like COL4 gene variants (=GBM weakness; see 🔓jasn.asnjournals.org/content/30/10/…) ...
17b) ... &
👉APOL-1 gene variants (=podocyte weakness; see 🔓karger.com/Article/FullTe…), suggesting that #DM promotes onset & progression of #CKD in #CKD-susceptible individuals, thus #diabetes = a RF for accelerated #CKD progression, esp when #CKD develops shortly after #DM onset
18) Whew! That's a lot of perspectives. Think on these--their relative strengths/weaknesses--and return tomorrow for more education & your link to 🆓CE/#CME! 👏to @kidneydoc101 @RenalFellowNtwk @swissnephro @RealDr_Pepper @KSusztak @SethiRenalPath @drjosflynn @StuartShankland
19) Thank you for coming back! You are learning from @hjanders_hans all about #CKD + #T2D while you earn 🆓CE/#CME! Hello to @kdjhaveri @KuppeChristoph @Tiff_Caza @AstridWeins @suz_allison @LinusButt @Renalpathsoc @JeanHouMD @ChristophWanne4 @mvaduganathan @KidneyPath
20) So considering all those perspectives confirms how complicated looking at #CKD through a lens of #T2D can be! The multifactorial origin of #CKD +/- #diabetes in adults: And then there's #aging, during which numerous RF for the onset of #CKD accumulate nature.com/articles/nrdp2…
21) Thus, with increasing age it becomes less and less likely that the origin of #CKD is a single disease. Thus in adults, targeting the unspecific mechanisms of #CKD progression and minimizing all RF for #CKD progression has become a management priority.
nature.com/articles/nrdp2…
22) Frequently, multiple factors combine that enhance single nephron #hyperfiltration & require structural #adaptation, for which human capacity is quite limited before irreversible injury occurs, e.g., #podocyte detachment from intolerable shear stress.
pubmed.ncbi.nlm.nih.gov/28992221/
23a) Learned from recent RCTs with unprecedented large effect sizes:
#Diabetes accelerates onset & progression of #CKD via…
👉forced ↑ #glucose reabsorption in the PT= ↑ metabolic PT stress = #hypoxia & #cytokine signaling & irreversible loss of PT cells
(cont)
23b)
👉increasing hemodynamic shear stress on #podocytes because SGLT2-mediated disabling of the #tubuloglomerularfeedback. Ultimately leads to #podocyte loss = #glomerulosclerosis
🔓pubmed.ncbi.nlm.nih.gov/24334175/
24) An integrated view of mechanisms leading to the structural changes of #CKD that are all accelerated by the presence of persistent hyperglycemia (= #diabetes) is also shown here:
See nature.com/articles/s4158…
25) Loss of #podocytes & PT cells both ↑ workload (hemodynamic & metabolic) to remaining #podocytes & PT cells, respectively, ending in an autoamplification loop of functional overload & progressive epithelial cell loss = #CKD progression = BAD NEWS
nature.com/articles/s4158…
26) These mechanisms apply to all forms of #CKD. #Diabetes is just one of many RF that create a dysbalance between #nephron no./capacity & metabolic demands of the body.
nature.com/articles/s4158…
27) This concept is poorly addressable in:
👉Cell culture studies (no hemodynamics, pressures, shear stress)
👉Rodent models (↑↑↑capacity to adapt to nephron overload vs. Humans
28a) What is the evidence for hemodynamic and metabolic nephron overload as key drivers of #CKD +/- #diabetes?
👉Rodents with #diabetes: identical overload but capacity for adaption ↑↑↑ prevents progressive #CKD: Reducing overload is key in humans
(cont)
28b)
👉#Pathology: glomerulomegaly in #diabetes = adaptation to #hyperfiltration
👉#RCTs: dual RAS/SGLT2 inhibition prevents progression of #CKD +/- #diabetes at unprecedented effect size (🔓nejm.org/doi/full/10.10…)
29a) How do #RAASi affect #nephron overload in #CKD +/- #diabetes?
👉The #RAS is a key stress response pathway activated in #diabetes, #kidneydisease and #heartfailure
(cont)
29b)
👉#RAASi open eff. arteriole = filtration pressure ↓ = #podocyte shear stress ↓ = #proteinuria ↓ = metabolic load to PT ↓
👉Better resilience of #podocytes & PT= remnant nephrons last little longer
👉#RAASi block profibrotic effects of #AT2
See
nejm.org/doi/full/10.10…
30a) How do #SGLT2i affect #nephron overload in #CKD +/- #diabetes beyond #RAASi?
👉Block Na+/glucose reabsorption in PT = less metabolic PT workload
(cont)
30b)
👉Reactivation of TG feedback = constriction of aff. arteriole = filtration pressure ↓ = #podocyte shear stress ↓ = #proteinuria
👉Better resilience of #podocytes and PT = remnant nephrons last a lot longer
👉Proximal diuretic effect improves #diabetes & #heartfailure
31) More insights from human #RCT about the pathophysiology of #CKD + #diabetes?
👉Mineralocorticoid receptor signaling, another pleiotrophic stress pathway, has non-redundant contributions to #CKD + #diabetes
See 🔓pubmed.ncbi.nlm.nih.gov/33264825/
(cont)
32)
👉Endothelin receptor signaling contributes to #CKD + #diabetes
See pubmed.ncbi.nlm.nih.gov/30995972/
👉CCL2/CCR2-related #kidney #inflammation is a downstream pathomechanism (low effect size)
See pubmed.ncbi.nlm.nih.gov/26268910/ and 🔓pubmed.ncbi.nlm.nih.gov/28186566/
33a) Let me summarize:
👉#DKD as a term should be used only for pts where #diabetes is the only or predominant cause of #CKD, which is rare in older adults with #T2D
👉Global epidemic & unmet need = #CKD + #diabetes
- Check @goKDIGO guidelines for tx of #diabetes in this setting
33b)
👉Reduce hemodynamic & metabolic overload of the remaining #nephrons to maximize #kidney lifespan. For this: (a) control all RF for hyperfiltration of the remaining #nephrons & (b) minimize tubular reabsorption of #salt, #glucose, & #protein
33c) Finally,
👉#Inflammation and #fibrosis are downstream pathomechanism, whether targeting these beyond dual #RAASi/SGLT2i will have additional effects is possible but currently unknown
34a) And let us conclude with our patient:
In an obese 53 YO w/proteinuria & #CKD after only 2Y of #T2D, #DKD is unlikely. More likely diagnosis: #CKD + #T2D (consider work-up for proteinuria, e.g., COL4 variants/IgAN)
34b) Therapy: Dual #RAASi/SGLT2i, consider triple #CKD therapy by adding #MRA. The #SGLT2i could improve A1c, BMI, BP & reduce the risk of #hyperkalemia
34c) Target-BMI <25, -BP 120/80 w/o dihydropyridine CCB, minimize dietary salt, no smoking, regular physical activity, avoid #NSAID, #PPI or other nephrotoxins. Comprehensive care!
35) And that's it! YOU MADE IT! 0.5h CE/#CME credit. Go claim your certificate at ckd-ce.com/dkd9/. I am @hjanders_hans and I invite you to FOLLOW @ckd_ce (and @cardiomet_ce) for more outstanding education and credit for 🇪🇺🇬🇧🇨🇦🇺🇸 clinicians!

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with @CKD_ce

@CKD_ce Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ckd_ce

Aug 23
1a) Welcome to one of our favorite events on the @academiccme #accredited #tweetorial feeds: a takeover of our programming from @GoggleDocs! The focus of this tweetorial is data from #ADA2022 on #SGLT2i beyond cardiac disease. Our expert author is @GoggleDocs' @drpatrickholmes. Image
1b) Check out our other #ADA2022 recap #tweetorial by new @GoggleDocs family member @Ines_VFonseca who focused on the cardiac data presented: ckd-ce.com/dkd13_ada22a/
2) This program is #accredited for CE/#CME #physicians #physicianassociates #nurses #pharmacists #nursepractitioners & is supported by an educational grant from the Boehringer Ingelheim Pharmaceuticals Inc and Eli Lilly Company. It is intended for healthcare professionals.
Read 59 tweets
Aug 3
1) Welcome to our new #accredited #tweetorial which is Part 2 of a 2-part "highlights" program on new #SGLT2i & #DKD data presented at @ERAkidney #ERA22. #Physicians #nurses #pharmacists #PAs and #NPs can all earn 0.5h CE/#CME by following this 🧵!
2a) @ERAkidney #ERA22 is a primary international scientific symposium for interaction and exchange among basic scientists and clinicians working in #Nephrology. Our expert author is Dr. Clara García Carro (@ClaraGCarro) from San Carlos Clinical Hospital (Madrid, Spain).
2b) Be sure to check out the first half of this #ERA22 recap from my colleague @shbermejo, and get MORE 🆓CE/#CME at ckd-ce.com/dkd12_ERA22a/. Join me in following @ckd_ce for the BEST in #cardiorenal education delivered entirely by #tweetorial!
Read 48 tweets
Jul 26
1) Welcome to our new #accredited #tweetorial which is Part 1 of a 2-part "highlights" program on new #SGLT2i & #DKD data presented at @ERAkidney #ERA22. #Physicians #nurses #pharmacists #PAs and #NPs can all earn 0.5h CE/#CME by following this thread!
2) @ERAkidney #ERA22 is a primary international scientific symposium for interaction and exchange among basic scientists and clinicians working in #Nephrology. It was held in May. Our expert author is Dr. Sheila Bermejo (@shbermejo) from @vallhebron in Barcelona, Spain.
3) This program is #accredited for CE/#CME & is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance. It is not intended for US- or UK-based based HCPs. Accreditation statement & faculty disclosures at ckd-ce.com/disclosures/.
Read 43 tweets
Jul 7
1) Welcome to a new #accredited #tweetorial on optimizing the role of the pharmacist in managing cardiometabolic disease! Accredited for 0.50 hr for #physicians #nurses #pharmacists! Expert faculty is Snehal Bhatt PharmD @SnayCardsPharmD of @BIDMChealth. Image
2a) This educational activity is supported by grants from Bayer, Otsuka, & Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly Company. See archived programs, all by expert authors, still available for credit at ckd-ce.com.
2b) Accreditation statement and faculty disclosures are at ckd-ce.com/disclosures/. We are your ONLY source for accredited education in CKD and #cardiorenal disease delivered wholly on Twitter. FOLLOW US!
Read 24 tweets
May 17
1) Welcome to our #accredited #tweetorial on optimal mgt of #hyperkalemia in the patient with #CKD. Earn 0.5h #CME/CE credit by following this thread. I am Sourabh Sharma MD DNB FASN 🇮🇳 @iamnephrologist & u have found the ONLY source for CE credit delivered entirely on Twitter!
2) This program is supported by educational grants from AstraZeneca and Bayer & is intended for #healthcare providers. See faculty disclosures ckd-ce.com/disclosures/. Educational credit for #physicians #physicianassociate #nurses #nursepractitioners #pharmacists 🇺🇸🇨🇦🇪🇺🇬🇧
3) Potassium was first isolated by Humphry Davy in 1807 by electrolysis (Coined word from “Potash” [Dutch]). The periodic table symbol K was derived from kali (alkali) [Arabic].
en.wikipedia.org/wiki/Potassium
#NephroNotes #NephPearls #FOAMed #MedEd @MedTweetorials #CardioTwitter
Read 36 tweets
Apr 27
1) Welcome to our new #accredited #tweetorial on the Pathophysiology of #DKD in #T2D: Traditional Teaching and New Insights. Our expert author is Hans-Joachim Anders, MD, @hjanders_hans from @LMU_Uniklinikum of @LMU_Muenchen
2) This #accredited #tweetorial series on the foundations of #kidneydisease #DKD through the lens of #T2D is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance and is intended for healthcare providers.
3) This activity is accredited for #physicians #physicianassociates #nurses #NPs #pharmacists 🇺🇸🇪🇺🇬🇧🇨🇦. Past programs still eligible for credit are at ckd-ce.com. Faculty disclosures are at ckd-ce.com/disclosures/. FOLLOW US for regular programs by expert faculty!
Read 48 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(